




Searching News Database: Lumos Pharma
HSMN NewsFeed - 3 Dec 2021
Chemomab Therapeutics Names David M. Weiner, MD as Interim Chief Medical Officer
Chemomab Therapeutics Names David M. Weiner, MD as Interim Chief Medical Officer
HSMN NewsFeed - 21 Jun 2016
Lumos Pharma Appoints Carol A. Dutch As Senior Director, Patient Engagement
Lumos Pharma Appoints Carol A. Dutch As Senior Director, Patient Engagement